Argenx Se (ARGX) EPS (Basic) Growth (1y) (2017 - 2026)
Argenx Se (ARGX) EPS (Basic) Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,151.81% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 1,201.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 88.81% |
| Mar 31, 2026 | 112.82% |
| Dec 31, 2025 | -32.77% |
| Sep 30, 2025 | 268.73% |
| Jun 30, 2025 | 721.54% |
| Mar 31, 2025 | 366.84% |
| Dec 31, 2024 | 845.59% |
| Sep 30, 2024 | 221.73% |
| Jun 30, 2024 | 128.88% |
| Mar 31, 2024 | -299.85% |
| Dec 31, 2023 | -144.31% |
| Sep 30, 2023 | -129.35% |
| Jun 30, 2023 | -113.66% |
| Mar 31, 2023 | 111.91% |
| Dec 31, 2022 | 84.75% |
| Sep 30, 2022 | 193.80% |
| Jun 30, 2022 | 2,663.46% |
| Mar 31, 2022 | -638.82% |
| Dec 31, 2021 | -8.62% |
| Sep 30, 2021 | -17.17% |